Apoptosis-resistant NS/0 E1B-19K myelomas exhibit increased viability and chimeric antibody productivity under cell cycle modulating conditions

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1023/A:1008054403470
AuthorSearch for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. NRC Biotechnology Research Institute
FormatText
TypeArticle
Journal titleCytotechnology
Volume28
Issue1-3
Pages189203; # of pages: 15
Subjectapoptosis; cell cycle; E1B-19K; hydroxyurea; hyperosmosis; hypertonic; monoclonal antibodies; OptiMAbTM; thymidine
Abstract
Publication date
NRC number41439
NPARC number3538945
Export citationExport as RIS
Report a correctionReport a correction
Record identifierfb46bf38-6308-4892-a867-bd065d7b0df8
Record created2009-03-01
Record modified2019-05-01
Date modified: